Spruce Biosciences Statistics
Total Valuation
SPRB has a market cap or net worth of $128.06 million. The enterprise value is $80.36 million.
| Market Cap | 128.06M |
| Enterprise Value | 80.36M |
Important Dates
The next estimated earnings date is Wednesday, August 12, 2026, after market close.
| Earnings Date | Aug 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SPRB has 2.75 million shares outstanding. The number of shares has increased by 72.07% in one year.
| Current Share Class | 2.75M |
| Shares Outstanding | 2.75M |
| Shares Change (YoY) | +72.07% |
| Shares Change (QoQ) | +5.72% |
| Owned by Insiders (%) | 3.60% |
| Owned by Institutions (%) | 36.70% |
| Float | 2.40M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.83 |
| P/TBV Ratio | 3.67 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.67, with a Debt / Equity ratio of 0.21.
| Current Ratio | 4.67 |
| Quick Ratio | 4.59 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -46.71 |
Financial Efficiency
Return on equity (ROE) is -148.85% and return on invested capital (ROIC) is -54.95%.
| Return on Equity (ROE) | -148.85% |
| Return on Assets (ROA) | -37.16% |
| Return on Invested Capital (ROIC) | -54.95% |
| Return on Capital Employed (ROCE) | -76.63% |
| Weighted Average Cost of Capital (WACC) | 21.86% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.66M |
| Employee Count | 14 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +421.78% in the last 52 weeks. The beta is 3.34, so SPRB's price volatility has been higher than the market average.
| Beta (5Y) | 3.34 |
| 52-Week Price Change | +421.78% |
| 50-Day Moving Average | 48.67 |
| 200-Day Moving Average | 70.95 |
| Relative Strength Index (RSI) | 52.23 |
| Average Volume (20 Days) | 60,703 |
Short Selling Information
The latest short interest is 415,860, so 15.11% of the outstanding shares have been sold short.
| Short Interest | 415,860 |
| Short Previous Month | 359,389 |
| Short % of Shares Out | 15.11% |
| Short % of Float | 17.30% |
| Short Ratio (days to cover) | 4.57 |
Income Statement
| Revenue | n/a |
| Gross Profit | -10.36M |
| Operating Income | -26.11M |
| Pretax Income | -37.19M |
| Net Income | -37.19M |
| EBITDA | -33.74M |
| EBIT | -34.01M |
| Earnings Per Share (EPS) | -$38.62 |
Balance Sheet
The company has $54.08 million in cash and $7.12 million in debt, with a net cash position of $46.96 million or $17.06 per share.
| Cash & Cash Equivalents | 54.08M |
| Total Debt | 7.12M |
| Net Cash | 46.96M |
| Net Cash Per Share | $17.06 |
| Equity (Book Value) | 34.65M |
| Book Value Per Share | 25.25 |
| Working Capital | 43.25M |
Cash Flow
In the last 12 months, operating cash flow was -$29.33 million and capital expenditures -$10,000, giving a free cash flow of -$29.34 million.
| Operating Cash Flow | -29.33M |
| Capital Expenditures | -10,000 |
| Depreciation & Amortization | 267,000 |
| Net Borrowing | 12.49M |
| Free Cash Flow | -29.34M |
| FCF Per Share | -$10.66 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SPRB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -72.07% |
| Shareholder Yield | -72.07% |
| Earnings Yield | -29.21% |
| FCF Yield | -23.05% |
Analyst Forecast
The average price target for SPRB is $151.00, which is 224.52% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $151.00 |
| Price Target Difference | 224.52% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 7, 2025. It was a reverse split with a ratio of 1:75.
| Last Split Date | Aug 7, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:75 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |